A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver

By sjmartinez • December 11, 2024

Perry AS, Hadad N, Chatterjee E, Jimenez-Ramos M, Farber-Eger E, Roshani R, Stolze LK, Betti MJ, Zhao S, Huang S, Martens L, Kendall TJ, Thone T, Amancherla K, Bailin S, Gabriel CL, Koethe J, Carr JJ, Terry JG, Vaitinadin NS, Freedman JE, Tanriverdi K, Alsop E, Van Keuren-Jensen K, Sauld JFK, Mahajan G, Khan SS, Colangelo L, Nayor M, Fisher-Hoch S, McCormick JB, North KE, Below JE, Wells QS, Abel ED, Kalhan R, Scott C, Guilliams M, Gamazon ER, Fallowfield JA, Banovich NE, Das S, Shah R. A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver. Cell Rep Med. 2024 Dec 4:101871. doi: 10.1016/j.xcrm.2024.101871. Epub ahead of print. PMID: 39657669.

Tags: diabetes, Endocrinology, liver-on-a-chip, Metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease, proteomics, Publications

Colliding crises: The global diabetes pandemic meets climate change-A scoping review

Perez JS, Hudson H, Araneta J, Bedell B, Aikins AD, Dugas LR, Eid M, Eshac Y, Fariduddin M, Fariduddin M, Jong K, Kapwata T, Luke[...]

Glymphatic system impairment in type II diabetes mellitus adults

Roy B, Lubera V, Singh KR, Singh A, Karunamuni DR, Kosoyan DE, Carrier M, Choi SE, Freeby MJ, Kumar R. Glymphatic system impairment in type[...]

Osilodrostat for Cyclic Cushing Disease

Rhyu J, Yu R. Osilodrostat for Cyclic Cushing Disease. AACE Endocrinol Diabetes. 2025 Sep 30;13(1):17-21. doi: 10.1016/j.aed.2025.09.011. PMID: 41641307; PMCID: PMC12866165.